The current status of gene therapy in bladder cancer-Reference-Cited by-同舟云学术

The current status of gene therapy in bladder cancer

Published:2023-04-25 Issue:5 Volume:23 Page:531-543
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Tholomier Côme¹^ORCID,Martini Alberto¹,Mokkapati Sharada²^ORCID,Dinney Colin P.²^ORCID

Affiliation:

1. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Department of Urology,Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2203385

Reference98 articles.

1. US Food and Drug Administration. What is gene therapy? 07/2018 [10/2022]. Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy.

2. Terapia gênica: o que é, o que não é e o que será

3. The Promise and the Hope of Gene Therapy

4. Gene Therapy for Human Genetic Disease?

5. History of gene therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GAS6-AS1 drives bladder cancer progression by increasing MMP7 expression in a ceRNA- and RBP-dependent manner;Translational Oncology;2024-10

2. Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy;Journal of Experimental & Clinical Cancer Research;2024-08-12

3. A biocompatible glycogen based nanoparticle coating with lipid bilayer for intracellular delivery of survivin siRNA to HeLa cells;Journal of Drug Delivery Science and Technology;2024-02

4. Viral vector‐based cancer treatment and current clinical applications;MedComm – Oncology;2023-10-29

5. Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer;Expert Opinion on Pharmacotherapy;2023-10-19